當前位置：首頁期刊介紹(非官網(wǎng))

Annals Of Translational MedicineSCIE

國際簡稱：ANN TRANSL MED 參考譯名：轉(zhuǎn)化醫(yī)學年鑒

中科院分區(qū)
4區(qū)

基本信息：: ISSN：2305-5839; E-ISSN：2305-5847; 是否OA：未開放; 是否預警：是; TOP期刊：否

出版信息：: 出版地區(qū)：China; 出版商：AME PUBL CO; 出版語言：English; 出版周期：24 issues/year; 出版年份：2013; 研究方向：Multiple

評價信息：

發(fā)文數(shù)據(jù)：: Gold OA文章占比：99.49%; 研究類文章占比：85.09%; 年發(fā)文量：0; 自引率：0.1165...; 開源占比：0.9949; 出版撤稿占比：0.0007...; 出版國人文章占比：0.41; OA被引用占比：0.7842...

投稿咨詢加急見刊

英文簡介期刊介紹中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Annals Of Translational Medicine期刊介紹

Annals Of Translational Medicine was founded in 2013 and is published bimonthly by the domestic AME Publishing Company group. and observational research, aiming to publish the most practical and up-to-date information in medical research, thereby broadening readers' horizons and promoting the translation between research theory and clinical application.

The editor-in-chief of the journal includes Professor Wang Xuehao (Academician of the Chinese Academy of Engineering), Department of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Professor Sun Yinghao (Academician, Chinese Academy of Engineering), Department of Urology, Changhai Hospital, Naval Medical University, and Professor Calvin S. H. Ng, Prince of Wales Hospital, Chinese University of Hong Kong.

期刊簡介Annals Of Translational Medicine期刊介紹

《Annals Of Translational Medicine》自2013出版以來，是一本醫(yī)學優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學研究結(jié)果，并為醫(yī)學各個領域的原創(chuàng)研究提供一個展示平臺，以促進醫(yī)學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學領域的最新進展和新發(fā)現(xiàn)新突破等。該刊近一年被列入預警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：
醫(yī)學
MEDICINE, RESEARCH & EXPERIMENTAL
SCIE
中科院4區(qū)
預警

中科院SCI分區(qū)Annals Of Translational Medicine 中科院分區(qū)

中科院 2022年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區(qū)	小類學科	分區(qū)
醫(yī)學	4區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學：研究與實驗 ONCOLOGY 腫瘤學	4區(qū) 4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎，運用科學計量學方法對國際、國內(nèi)學術期刊依據(jù)影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構(gòu)的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機構(gòu)的廣泛認可。

中科院分區(qū)表 將所有期刊按照一定指標劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學術期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Annals Of Translational Medicine JCR分區(qū)

2023-2024 年最新版

按JIF指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學術文獻質(zhì)量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計

國家/地區(qū)數(shù)量
CHINA MAINLAND1760
USA766
Italy275
Japan131
France126
South Korea125
Spain113
England107
GERMANY (FED REP GER)106
Greece85

本刊中國學者近年發(fā)表論文

1、EML4-ALK rearrangement of lung large cell neuroendocrine carcinoma: a case report
Author: Chen, Dianjun; Ma, Shuangyue; Sun, Lili; Lang, Yuehong; Yang, Boyan

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-6062
2、A pan-cancer analysis of the expression and prognostic significance of PDRG1
Author: Liu, Zhen; Huang, Ketuan; He, Yongfei; Hao, Shuqing; Wei, Zhongliu; Peng, Tao

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-5439
3、Research progress and clinical evaluation of histotripsy: a narrative review
Author: Li, Shuaiqi; Wei, Yufan; Zhang, Boya; Li, Xiru

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-2578
4、Peroxiredoxin 6 alleviates high glucose-induced inflammation and apoptosis in HK-2 cells by inhibiting TLR4/NF-Kappa B signaling
Author: Wu, Hao; Wu, Rong; Liu, Tianxi; Ma, Hongbin; Xue, Guozhong; Liu, Minglong

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-6063
5、Establishment and validation of a diagnostic nomogram for significant histopathologic changes of hepatic injury in HBV- infected patients
Author: Sun, Lin-Lin; Wang, Min; Zhang, Nan-Nan; Chen, Ming-Xia; Li, Yuan-Yuan; Zhang, Shuai; Qin, Cheng-Yong

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-5840
6、The prognostic value of neutrophil-to-lymphocyte ratio in de novo stage IV breast cancer: a retrospective cohort study
Author: Shao, Bin; Li, Huiping; Liu, Xiaoran; Song, Guohong; Jiang, Hanfang; Yan, Ying; Zhang, Ruyan; Ran, Ran; Zhang, Jiayang; Liu, Yaxin; Wang, Huan; Wang, Jing; Di, Lijun

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-5612
7、The diagnostic value of novel ultrasound attenuation analysis in detecting liver steatosis identified by the controlled attenuation parameter: a diagnostic accuracy study
Author: Jiang, Meijuan; Zhang, Xuanxuan; Wu, Xiaojin; Xu, Zhikang; Pan, Jianlian; He, Huiling; Luo, Yunkai; Chen, Jian

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-5821
8、Machine learning screening for Parkinson's disease-related cuproptosis-related typing development and validation and exploration of personalized drugs for cuproptosis genes
Author: Wu, Ji; Qin, Chengjian; Cai, Yuankun; Zhou, Jiabin; Xu, Dongyuan; Lei, Yu; Fang, Guoxing; Chai, Songshan; Xiong, Nanxiang

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-5756